2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
2
Sponsor Class
OTHER
7
NETWORK
2
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
265
Leukemia
183
Carcinoma, Non-Small-Cell Lung
168
Lymphoma
159
Lung Neoplasms
148
Prostatic Neoplasms
134
Precursor Cell Lymphoblastic Leukemia-Lymphoma
130
Ovarian Neoplasms
117
Colorectal Neoplasms
115
Sarcoma
108
Central Nervous System Neoplasms
107
Head and Neck Neoplasms
98
Leukemia, Myeloid, Acute
95
Multiple Myeloma
93
Squamous Cell Carcinoma of Head and Neck
83
Rectal Neoplasms
77
Colonic Neoplasms
71
Uterine Cervical Neoplasms
65
Neoplasm Metastasis
65
Neuroblastoma
64
Carcinoma, Ovarian Epithelial
64
Brain Neoplasms
64
Neoplasms
63
Fallopian Tube Neoplasms
62
Lymphoma, Large B-Cell, Diffuse
61
Melanoma
59
Astrocytoma
59
Leukemia, Lymphocytic, Chronic, B-Cell
56
Burkitt Lymphoma
56
Hodgkin Disease
55
Interventions
eribulin
1
Trabectedin
1
Doxorubicin
1
Dacarbazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Solitary Fibrous Tumors
×
Clear all
NCT03023124
2024-12-09
STRADA
Italian Sarcoma Group
Phase 2
Completed
23 enrolled
NCT03840772
2024-09-20
ERASING
Italian Sarcoma Group
Phase 2
Completed
16 enrolled